Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study-Reference-Cited by-同舟云学术

Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study

Published:2017-12 Issue:6 Volume:27 Page:591-595
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Schinzari Giovanni,Rossi Ernesto,Cassano Alessandra,Dadduzio Vincenzo,Quirino Michela,Pagliara Monica,Blasi Maria A.,Barone Carlo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference28 articles.

1. Incidence of uveal melanoma in the United States 1973–1997;Singh;Opthalmology,2003

2. Very long-term prognosis of patients with malignant uveal melanoma;Kujala;Invest Ophthalm Vis Sci,2003

3. Development of metastatic disease after enrollment in the COMS trial for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No 26;Diener-West;Arch Ophthalmol,2005

4. Survival of patients with metastases from uveal melanoma;Gragoudas;Ophtalmology,1991

5. Metastatic uveal melanoma;Singh;Ophthalmol Clin North Am,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi‐institutional study;Cancer Medicine;2023-07-06

2. Reduction-responsive dextran-based Pt(IV) nano-prodrug showed a synergistic effect with doxorubicin for effective melanoma treatment;International Journal of Biological Macromolecules;2023-04

3. Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients;Cancers;2023-01-13

4. Alantolactone inhibits oesophageal adenocarcinoma cells through nuclear factor erythroid 2‐related factor 2‐mediated reactive oxygen species increment;Basic & Clinical Pharmacology & Toxicology;2022-12-21

5. Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma;Investigative Opthalmology & Visual Science;2022-12-14